uniQure N.V. (QURE) stock
QURENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30224% above fair value
$20.78−1.10 (-5.03%)
Close on Nov 17, 2026Market cap $1.44BP/E –Yield –
uniQure EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
uniQure's EV/EBITDA was 2.5× on Jul 29, 2022.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Jul 29, 2022 | 2.5× | +1.0 |
| 2021 | Dec 31, 2021 | 1.5× | – |
See a number that looks wrong?